🇺🇸 FDA
Pipeline program

pneumococcal disease prevention

S20210036-5

Phase 3 mab active

Quick answer

pneumococcal disease prevention for Pneumococcal Vaccines is a Phase 3 program (mab) at Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Indication
Pneumococcal Vaccines
Phase
Phase 3
Modality
mab
Status
active

Clinical trials